According to the analysed literature, the most prominent targets in the TME could be TGF-β, produced by the tumour itself, TAMs, MDSCs, iCAFs and stimulation of anti-inflammatory response, and reduced infiltration of the CD8+ Tc1. This evidence concerns the gene CD8A and neoplasm.